Featured Posts

Despite treatment advances, ‘much to improve upon’ in high-risk neuroblastoma

July 13, 2020

As outcomes for high-risk neuroblastoma improve, refining treatment approaches in order to reduce late-term effects will be key, according to Giselle Sholler, MD.

 

Read more: https://www.healio.com/news/hematology-oncology/20200709/despite-treatment-advances-much-to-improve-upon-in-highrisk-neuroblastoma

Please reload

I'm busy working on my blog posts. Watch this space!

Please reload

Recent Posts
Please reload

Archive